AVITA Medical, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $70.9M | $63.9M | $50.1M | $34.4M | — |
| Cost of revenue | $12.8M | $9.1M | $7.8M | $6.0M | — |
| Gross profit | $58.8M | $55.2M | $42.4M | $28.4M | — |
| Research and development | $20.8M | $20.4M | $20.8M | $13.9M | — |
| Operating expenses | $101.3M | $111.8M | $86.4M | $59.1M | — |
| Operating income | -$42.5M | -$56.6M | -$42.7M | -$27.5M | — |
| Interest expense | $5.0M | $5.4M | $1.1M | $16,000 | — |
| Pretax income | -$48.6M | -$61.8M | -$35.3M | -$26.6M | — |
| Income tax expense | $11,000 | $54,000 | $66,000 | $36,000 | — |
| Net income | -$48.6M | -$61.8M | -$35.4M | -$26.7M | — |
| Balance Sheet | |||||
| Cash and equivalents | $10.2M | $14.1M | $22.1M | $18.2M | $55.5M |
| Current assets | $35.5M | $57.0M | $104.0M | $87.5M | $92.1M |
| Total assets | $56.4M | $79.7M | $111.6M | $98.3M | $116.0M |
| Current liabilities | $62.7M | $20.2M | $13.2M | $10.7M | $9.1M |
| Total liabilities | $73.0M | $75.0M | $61.9M | $13.0M | $11.4M |
| Total debt | $40.0M | $40.0M | — | — | — |
| Stockholders' equity | -$16.6M | $4.5M | $49.1M | $84.7M | $104.6M |
| Cash Flow Statement | |||||
| Cash from operations | -$31.2M | -$48.9M | -$38.0M | -$19.1M | — |
| Depreciation and amortization | $2.3M | $1.1M | $632,000 | $568,000 | — |
| Stock-based compensation | $9.5M | $13.5M | $8.4M | $7.0M | — |
| Capital expenditure | $1.0M | $9.2M | $1.4M | $452,000 | — |
| Free cash flow | -$32.2M | -$58.1M | -$39.4M | -$19.5M | — |
| Impairments | $0 | $0 | $0 | $0 | — |
Shares outstanding 30.8M · Free float 97.8%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.